PhD: University of the Witwatersrand, Johannesburg South Africa, 2016.
PG Diploma: Pharmaceutical Regulatory Affairs, Hamdard University, New Delhi, India, 2008.
MSc: Gurukula Kangri Vishwavidyalaya, Haridwar, India, 2004.
MPH: University of the Witwatersrand, Johannesburg, South Africa, 2024.
Pregnant women; newborn and infant health; vaccine preventable infections and deaths
Immunological correlates of protection; development of new vaccine candidates; infectious diseases surveillance; sero-surveillance and immunology studies; vaccine clinical and pre-clinical studies
Infectious Diseases
Vaccine value profile for Klebsiella pneumoniae. Vaccine. 2024; 42:S125-S141.
Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study. Vaccine. 2024; 42:3564-3571.
Post-acute sequelae of SARS-CoV-2 infection in health care workers from South Africa. Oxford Open Immunology. 2024; 5:iqae001.
Prevalence and Levels of Anti-SARS-CoV-2 Antibodies in the Eswatini Population and Subsequent Severity of the Fourth COVID-19 Epidemic Wave. 2024; 4:317-333.
Combinatorial multimer staining and spectral flow cytometry facilitate quantification and characterization of polysaccharide-specific B cell immunity. Communications Biology. 2023; 6:1095.
Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study. Vaccines. 2023; 11.
Serotype distribution and antimicrobial susceptibility profile of invasive group B streptococcal disease-in South Indian population. Indian Journal of Medical Microbiology. 2023; 45:100392.
Immune responses against group B Streptococcus monovalent and pentavalent capsular polysaccharide tetanus toxoid conjugate vaccines in Balb/c mice. iScience. 2023; 26:107380.
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. The New England Journal of Medicine. 2023; 389:215-227.
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nature Immunology. 2023; 24:1161-1172.